Alex KlarerDirector of MSAT and Acting Head of R&D at BioCentriq
Alex Klarer has a background in Chemical Engineering focused on bioprocessing and process engineering. He has held roles at Genentech and Hitachi where he led the translational process development for a range of cell therapies and ex-vivo gene therapies including T-cell immunotherapies, stem cell therapies, and MSC mediated immunoregulation. Alex also has experience developing novel technologies and applications to address gaps in manufacturing capabilities. He looks forward to continuing to partner with groundbreaking regenerative medicine companies and helping their therapies reach patients.